Creative Medical Technology Holdings (CELZ) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Creative Medical Technology Holdings (CELZ) over the last 17 years, with Q3 2025 value amounting to 0.96.
- Creative Medical Technology Holdings' Equity Ratio rose 35.6% to 0.96 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.96, marking a year-over-year increase of 35.6%. This contributed to the annual value of 0.95 for FY2024, which is 149.87% down from last year.
- According to the latest figures from Q3 2025, Creative Medical Technology Holdings' Equity Ratio is 0.96, which was up 35.6% from 0.96 recorded in Q2 2025.
- Creative Medical Technology Holdings' Equity Ratio's 5-year high stood at 0.98 during Q2 2022, with a 5-year trough of 2.8 in Q1 2021.
- In the last 5 years, Creative Medical Technology Holdings' Equity Ratio had a median value of 0.96 in 2024 and averaged 0.6.
- Data for Creative Medical Technology Holdings' Equity Ratio shows a peak YoY increase of 94673.76% (in 2022) and a maximum YoY decrease of 881.19% (in 2022) over the last 5 years.
- Over the past 5 years, Creative Medical Technology Holdings' Equity Ratio (Quarter) stood at 0.91 in 2021, then decreased by 8.81% to 0.83 in 2022, then increased by 16.75% to 0.97 in 2023, then fell by 1.5% to 0.95 in 2024, then rose by 0.47% to 0.96 in 2025.
- Its Equity Ratio stands at 0.96 for Q3 2025, versus 0.96 for Q2 2025 and 0.97 for Q1 2025.